Lung cancer is the leading cause of cancer death worldwide. An appropriate staging is mandatory in order to define a tailored approach for each patient. Patients with locally advanced non-small cell lung cancer (NSCLC) represent a widely heterogeneous group of patients with lung cancers, and invasion of the chest wall and/or mediastinal organs with N2 disease. Even the involvement of N2 lymph nodes includes different subpopulations (single-, multi-level, and bulky disease). Due to this heterogeneity, the management of those patients poses a real challenge for surgeons, oncologists, and radiation oncologists.
This topic aims to offer a comprehensive overview of current treatments for patients with locally advanced NSCLC. Based on the model of a multidisciplinary team discussion, we invite thoracic surgeons, medical and radiation oncologists to share their opinions and present studies with long-term follow-up data inclusive patient-reported outcomes.
Submissions may include original research manuscripts, reviews, and perspectives on this important topic. Potential themes of interest include:
- Surgical approach in patients with locally advanced NSCLC
- Role of chemotherapy
- Role of radiotherapy
- The importance of staging
- Role of immunotherapy in a neoadjuvant or adjuvant setting
We aim to provide at the end a comprehensive overview ranging from the diagnosis to the state of the art treatment options in patients with locally advanced NSCLC.
Lung cancer is the leading cause of cancer death worldwide. An appropriate staging is mandatory in order to define a tailored approach for each patient. Patients with locally advanced non-small cell lung cancer (NSCLC) represent a widely heterogeneous group of patients with lung cancers, and invasion of the chest wall and/or mediastinal organs with N2 disease. Even the involvement of N2 lymph nodes includes different subpopulations (single-, multi-level, and bulky disease). Due to this heterogeneity, the management of those patients poses a real challenge for surgeons, oncologists, and radiation oncologists.
This topic aims to offer a comprehensive overview of current treatments for patients with locally advanced NSCLC. Based on the model of a multidisciplinary team discussion, we invite thoracic surgeons, medical and radiation oncologists to share their opinions and present studies with long-term follow-up data inclusive patient-reported outcomes.
Submissions may include original research manuscripts, reviews, and perspectives on this important topic. Potential themes of interest include:
- Surgical approach in patients with locally advanced NSCLC
- Role of chemotherapy
- Role of radiotherapy
- The importance of staging
- Role of immunotherapy in a neoadjuvant or adjuvant setting
We aim to provide at the end a comprehensive overview ranging from the diagnosis to the state of the art treatment options in patients with locally advanced NSCLC.
